维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="BLASZKOWSKY LS"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase 2 study of cetuximah in patients with advanced hepatocellular carcinoma 显示文摘	Zhu AX Stuart K Blaszkowsky LS etal	2007	Cancer2007，110，3：	1
2	Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer 显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，30：	1
3	Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced bili- ary-tract cancers and correlation of changes in 18-fluorodeoxyglu- cose PET with clinical outcome: a phase 2 study显示文摘	Zhu AX Meyerhardt JA Blaszkowsky LS	2010	Lancet Oncol2010，11，1：	1
4	Capecitabi- ne plus erlotinib in gemcitabine-refractory advanced pan- creatic cancer显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，30：	1
5	Efficacy and safety of gemcitabine,oxaliplatin,and bevacizumab in advanced biliarytract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome:a phase 2 study显示文摘	Zhu AX Meyerhardt JA Blaszkowsky LS	2010	Lancet Oncol2010，11，1：	1
6	Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma 显示文摘	Zhu AX Blaszkowsky LS Ryan DP	2006	J Clin Oncol2006，24，：	1
7	A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma显示文摘	Chan JA Blaszkowsky LS Enzinger PC		0，，06：	1
8	Capeeitabine plus erlotinib in gemcitabine - refractory advanced pancreatic cancer 显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，30：	1
9	Efficacy and safety of gemcitabine,oxaliplatin,and bevaeizumab in advanced biliarytract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome:a phase 2 study显示文摘	Zhu AX Meyerhardt JA Blaszkowsky LS		0，，01：	1
10	Phase 2 study Of cetuximab in patients with advanced hepatoceUular carcinoma 显示文摘	Zhu AX Stuart K Blaszkowsky LS et a	2007	Cancer2007，110，3：	1
11	A multi?center phase II trial of single - agent cetuximab in ad?vanced esophageal and gastric adenocarcinoma显示文摘	Chan JA Blaszkowsky LS Enzinger PC	2011	Ann Oncol2011，22，6：	1
12	FOLFIRI- NOX in locally advanced pancreatic cancer: the Massachu- setts General Hospital Cancer Center experience 显示文摘	Faris JE Blaszkowsky LS McDermott S	2013	Oncolo- gist2013，18，5：	1
13	Capeeitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，30：	1
14	Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary- tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study显示文摘	Zhu AX MeyerhardtJA Blaszkowsky LS	2010	Lancet Oncol2010，11，1：	1
15	Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer 显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，30：	1
16	Phase Ⅱ study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma显示文摘	Zhu AX Blaszkowsky LS Ryan DP	2006	Clin Oncol2006，24，12：	1
17	A phase II study of erlotinib in combination with capecitabine in pre- viously treated patients with metastatic pancreatic cancer 显示文摘	Blaszkowsky LS Kulke KH Ryan DP	2005	Proc Am Soc Clin Oncol2005，24，：	1
18	Phase II study of gemcitabineand oxaliplatin in combination with bevacizumab in patients withadvanced hepatocellular carcinoma 显示文摘	Zhu AX Blaszkowsky LS Ryan DP	2006	Journal of Clinical Oncology2006，24，：	1
19	Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer显示文摘	Kulke MH Blaszkowsky LS Ryan DP	2007	J Clin Oncol2007，25，：	1
20	A multicenter phaseⅡtrial of single agent cetuximab in advanced esophageal and gastric adenocarcinoma显示文摘	Chan JA Blaszkowsky LS Enzinger PC	2011	Ann Oncol2011，22，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示